SEATTLE--(BUSINESS WIRE)--ZymoGenetics, Inc. (NASDAQ:ZGEN), announced today that Douglas E. Williams, Ph.D., President and Chief Scientific Officer, will provide an overview of company activities at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference in New York City on February 6, 2008, at 8:00 a.m. Eastern Time.
